Doravirine injections were safe and long-lasting, but did not reach therapeutic levels
Black people and women are under-represented in anti-HIV drug studies
New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin
HIV drugs reduce feminising hormone levels by 36% in HIV-positive trans women, Thai study finds
Vigilance over HIV drug interactions still needed
One-third of people living with HIV in rural Tanzania report clinically relevant drug-drug interactions
How do we deal with apparent cases of PrEP failure?
New European HIV guidelines cater for multiple needs
